Literature DB >> 8798488

Biosynthesis and metabolism of 2-iodohexadecanal in cultured dog thyroid cells.

V Panneels1, P Macours, H Van den Bergen, J C Braekman, J Van Sande, J M Boeynaems.   

Abstract

2-Iodohexadecanal (2-IHDA) is a major thyroid iodolipid. It mimics the main regulatory effects of iodide on thyroid metabolism: inhibition of H2O2 production and of adenylyl cyclase. The biosynthesis of 2-IHDA and its metabolism have been investigated in cultured dog thyroid cells maintained in a differentiated state by forskolin. Incubation of these cells with [9,10-3H]hexadecan-1-ol or [9,10-3H]palmitic acid labeled several phospholipids, but [9, 10-3H]hexadecan-1-ol was selectively incorporated into plasmenylethanolamine. In the presence of an exogenous H2O2 generating system (glucose oxidase), iodide induced the production of [9,10-3H]2-IHDA from [9,10-3H]hexadecan-1-ol-labeled cells but not from [9,10-3H]palmitic acid-labeled cells. 2-IHDA was also generated during the lactoperoxidase-catalyzed iodination of brain and heart plasmalogens, and of ethyl hexadec-1-enyl ether, a synthetic vinyl ether-containing compound. Taken together, these results show that thyroid 2-IHDA is derived from plasmenylethanolamine via an attack of reactive iodine on the vinyl ether group. 2-Iodohexadecan-1-ol (2-IHDO) was also detected in these studies; it was formed later than 2-IHDA, and thyroid cells converted exogenous 2-IHDA into 2-IHDO in a time-dependent way. The ratio of 2-IHDO/2-IHDA increased with H2O2 production and decreased as a function of iodide concentration. An aldehyde-reducing activity was detected in subcellular fractions of the horse thyroid. No formation of 2-iodohexadecanoic acid could be detected. Reduction into the biologically inactive 2-IHDO is thus a major metabolic pathway of 2-IHDA in dog thyrocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798488     DOI: 10.1074/jbc.271.38.23006

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  The Na+/I- symporter (NIS): mechanism and medical impact.

Authors:  Carla Portulano; Monika Paroder-Belenitsky; Nancy Carrasco
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

2.  Regulation of thyroid oxidative state by thioredoxin reductase has a crucial role in thyroid responses to iodide excess.

Authors:  Suzana G Leoni; Edna T Kimura; Pilar Santisteban; Antonio De la Vieja
Journal:  Mol Endocrinol       Date:  2011-09-08

3.  {Omega}-oxidation of {alpha}-chlorinated fatty acids: identification of {alpha}-chlorinated dicarboxylic acids.

Authors:  Viral V Brahmbhatt; Carolyn J Albert; Dhanalakshmi S Anbukumar; Bryce A Cunningham; William L Neumann; David A Ford
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

Review 4.  Iodine as a potential endocrine disruptor-a role of oxidative stress.

Authors:  Małgorzata Karbownik-Lewińska; Jan Stępniak; Paulina Iwan; Andrzej Lewiński
Journal:  Endocrine       Date:  2022-06-20       Impact factor: 3.925

Review 5.  The chlorinated lipidome originating from myeloperoxidase-derived HOCl targeting plasmalogens: Metabolism, clearance, and biological properties.

Authors:  Elisa N D Palladino; Celine L Hartman; Carolyn J Albert; David A Ford
Journal:  Arch Biochem Biophys       Date:  2018-01-31       Impact factor: 4.013

6.  A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.

Authors:  Nancy Braverman; Rui Zhang; Li Chen; Graeme Nimmo; Sarah Scheper; Tammy Tran; Rupsa Chaudhury; Ann Moser; Steven Steinberg
Journal:  Mol Genet Metab       Date:  2009-12-11       Impact factor: 4.797

Review 7.  Redox interplay between mitochondria and peroxisomes.

Authors:  Celien Lismont; Marcus Nordgren; Paul P Van Veldhoven; Marc Fransen
Journal:  Front Cell Dev Biol       Date:  2015-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.